A Molecular Docking Approach to Evaluate the Pharmacological Properties of Natural and Synthetic Treatment Candidates for Use against Hypertension
Cardiovascular diseases (CVDs) have become the leading cause of disability and death worldwide, particularly in low- and middle-income countries. Hypertension, a major cause of CVD progression, is widely attributable to genetic, behavioral, and environmental risk factors. Among the genetic reasons,...
Main Authors: | Syed Awais Attique, Muhammad Hassan, Muhammad Usman, Rana Muhammad Atif, Shahid Mahboob, Khalid A. Al-Ghanim, Muhammad Bilal, Muhammad Zohaib Nawaz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | http://www.mdpi.com/1660-4601/16/6/923 |
Similar Items
-
Angiotensin Converting Enzyme (ACE)-Peptide Interactions: Inhibition Kinetics, In Silico Molecular Docking and Stability Study of Three Novel Peptides Generated from Palm Kernel Cake Proteins
by: Mohammad Zarei, et al.
Published: (2019-10-01) -
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis
by: Deep Bhowmik, et al.
Published: (2021-03-01) -
Considerations for Docking of Selective Angiotensin-Converting Enzyme Inhibitors
by: Julio Caballero
Published: (2020-01-01) -
A genetic algorithm for the ligand-protein docking problem
by: Camila S. de Magalhães, et al.
Published: (2004-01-01) -
A review on clinical, pathological characteristics and drug designing for COVID-19
by: Muhammad Usama Ashraf, et al.
Published: (2021-01-01)